1.Effect of multidisciplinary nursing care on acute exacerbation and pulmonary function improvement in patients with chronic obstructive pulmonary disease
Rong YANG ; Yuxing CAI ; Wei LI ; Yamei GUO ; Mei LU ; Min LYU
Chinese Journal of Practical Nursing 2018;34(13):975-979
Objective To study the effect of multidisciplinary rehabilitation nursing on the number of acute exacerbation, quality of life and pulmonary function in patients with chronic obstructive pulmonary disease (COPD). Methods A total of 1088 cases of COPD patients admitted to department of respiratory medicine from February 2015 to July 2016 were divided into the study group and the control group by random digits table method, 544 cases in each group. The control group was given COPD related health education and routine care. The study group was given comprehensive rehabilitation of multidisciplinary lung care. After 1 years, the mental status, dyspnea grade improvement, acute exacerbation and 6 min walk test distance (6MWD) were compared between the two groups. Results One year after intervention, 6MWD and the times of acute exacerbation in the study group were (450.32 ± 67.21)m and (0.37 ± 0.28) times, and (394.12 ± 63.17)m and (2.08 ± 1.65) times in the control group, the study group was better than the control group (t=2.064, 2.029, P<0.05). One year after intervention, the scores of mental state, function, symptom were 1.76 ± 1.02, 1.69 ± 1.01, 1.61 ± 0.79 in the study group respectively, and 2.10 ± 1.08, 2.08 ± 2.03, 1.79 ± 0.80 in the control group,the difference was statistically significant (t=2.051, 2.017, 2.103, P<0.05). Conclusions After comprehensive nursing intervention of multidisciplinary rehabilitation, COPD patients can not only have obvious improvement in lung function, but also reduce the frequency of acute exacerbation of COPD.
2.Study on injectable calcium sulfate bone cement rich in bioactivity
Dengxing LUN ; Feng LI ; Guoyu LI ; Yamei LYU ; Yongcheng HU
Chinese Journal of Orthopaedics 2021;41(16):1125-1133
Objective:To explore the effect of decalcified bone matrix (DBM) rich in biological activity on surgical-grade medical calcium sulfate, and to observe the change of different content of DBM on the physical and chemical properties of calcium sulfate, which provide theoretical basis for the preparation of calcium sulfate bone cement with osteogenic and injectable properties.Methods:DBM with weight content of 0, 5%, 10%, 20%, 30%, 40% was fully mixed with CSH. Dissolve 0.3 g of methyl cellulose in 10 ml of deionized water to prepare a 3% methyl cellulose solution. Methylcellulose solution was added according to the liquid-solid ratio of 0.4. The mixture was evenly stirred to form slurry, then the degradation rate, compressive strength, setting time and and pH value of calcium sulfate in vitrowas measured.Results:The initial setting time and final setting time of calcium sulfate were 4.96±0.20 and 5.83±0.12 min respectively. With the increase of DBM content, the initial setting time and final setting time increased significantly ( F=49.275, P<0.05; F=124.859, P<0.05). The compressive strength of pure calcium sulfate is 23.33±6.35 MPa; when the content is 40%, the compressive strength is only 3.33 MPa. With the increase of DBM content, the compressive strength first increased and then decreased; the content of 5%, 10%, 20% DBM had little effect on the compressive strength ( P>0.05), while the compressive strength of 30% and 40% groups decreased significantly ( t=3.259, P<0.05). DBM with different contents can significantly change the degradation rate of calcium sulfate complex. When the content of DBM is 30% and 40%, the complete degradation time in vivo is only 10 d, while the degradation rate of calcium sulfate is 63% in 30 d. At any time point in vitro degradation, DBM had no significant effect on the pH value of calcium sulfate complex culture medium, and the change law was consistent with that of pure calcium sulfate. Conclusion:With the increase of DBM content, the degradation rate is gradually accelerated, the compressive strength is reduced, and the setting time is prolonged, which is not conducive to the preparation of injectable calcium sulfate cement.
3.Donor-derived cell-free DNA can discriminate acute rejection types after kidney transplantation
Yamei CHENG ; Luying GUO ; Wenhua LEI ; Junhao LYU ; Pengpeng YAN ; Jia SHEN ; Meifang WANG ; Qin ZHOU ; Huiping WANG ; Jianghua CHEN ; Rending WANG
Chinese Journal of Nephrology 2022;38(1):32-38
Objective:To explore the value of detecting plasma donor-derived free DNA (dd-cfDNA) fraction in distinguishing antibody mediated-rejection (ABMR) and T cell-mediated rejection (TCMR) of renal allografts.Methods:Patients with acute rejection confirmed by allograft biopsy in the First Affiliated Hospital of Medical College of Zhejiang University from December 1, 2017 to July 18, 2019 were retrospectively included. Based on pathological classification of Banff renal allograft rejection in 2017, the patients were divided into ABMR group and TCMR group, and the latter was subdivided into TCMR Ⅰ subgroup and TCMR Ⅱ subgroup. The second generation sequencing and target region capture were used to detect candidates' peripheral blood dd-cfDNA. The demographic and clinicopathological data of the two groups were compared. The receiver operating characteristic curve (ROC) was used to evaluate the differential value of plasma dd-cfDNA and serum creatinine levels in two kinds of acute renal allograft rejection.Results:A total of 60 patients with acute rejection of renal transplantation were enrolled in this study, including 42 patients in TCMR group and 18 patients in ABMR group. The plasma dd-cfDNA percentage (%) in the ABMR group was significantly higher than that in the TCMR group [2.33(1.19, 4.30)% vs 0.98(0.50, 1.82)%, P=0.001]. The absolute value of dd-cfDNA in ABMR group was obviously higher than that in TCMR group [0.94(0.60, 2.27) ng/ml vs 0.43(0.20, 0.96) ng/ml, P=0.003]. ROC analysis to discriminate TCMR from ABMR showed that, the area under the curve ( AUC) of dd-cfDNA% was 0.76(95% CI 0.64-0.88), when the threshold was 1.11%, the sensitivity and specificity were 88.89% and 59.52%, respectively; the AUC of absolute value of dd-cfDNA was 0.74(95% CI 0.61-0.86), when the threshold was 0.53 ng/ml, the sensitivity was 88.89% and the specificity was 54.76%. TCMR subgroups were further analyzed, there was no significant difference between TCMR subgroups on the absolute value and percentage of dd-cfDNA (both P>0.05); dd-cfDNA% in ABMR group was apparently higher than that in TCMRⅠ subgroups ( P=0.008) and TCMRⅡsubgroup ( P=0.030). The absolute value of dd-cfDNA in ABMR group was significantly higher than that in TCMRⅠsubgroups ( P=0.003). Conclusion:Plasma dd-cfDNA level may help to distinguish between ABMR and TCMR rejection.